| English Alias: |
Febuxostat;Tei-6720;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid;2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid;2-(3-Cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic Acid;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid;TMX 67;Febuxostat impurity;2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic Acid,This product is unavailable;Adenuric;Febuxostat (This product is unavailable in the U.S.);Febuxostat,This product is unavailable;TEI 6720;Uloric;UNII-101V0R1N2E;2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid;Atenuri;2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic Acid;Febuxostat 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid; 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carb;Feburic;Febuxostat (Uloric);2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid;2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID;C16H16N2O3S;101V0R1N2E;5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy);BRD-K48367671-001-01-8;5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-;Q-100164;Uloric (TN);Q417296;2-(3-cyano-4-isobutyloxy)-phenyl-4-methyl-5-thiazolecarboxylic acid;AM20090760;AB01274796_03;BDBM50320491;CCG-213303;Febuday;FEBUXOSTAT [WHO-DD];NSC 758874;FD7322;FEBUXOSTAT [INN];BQSJTQLCZDPROO-UHFFFAOYSA-N;SPIRAMYCINADIPATE;Febuxostatum;Goutex;FEBUXOSTAT [EMA EPAR];AKOS015841695;BCP9000679;FEBUXOSTAT [JAN];2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid;D01206;MX-67;M04AA03;SW219283-1;DB04854;CS-0403;2-(3-Cyano-4-isobutoxy-phenyl)-4-me;F0847;HMS3868J03;NCGC00182059-02;NCGC00182059-03;SR-01000940023-2;BC164443;EN300-122360;5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-;SMR002529566;TMX-67;CAS-144060-53-7;HMS3673M21;S1547;MLS004774136;BCP02342;Tox21_113004_1;HMS3655C03;SR-01000940023;GTPL6817;Tox21_113004;HMS3743I09;2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-1,3-thiazole-5-carboxylic acid;SCHEMBL249339;2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid;FT-0601639;Donifoxate;NSC-758874;HY-14268;Pharmakon1600-01504286;AB01274796-01;Z1541759499;BCPP000233;FEBUXOSTAT [ORANGE BOOK];WZB81950;PB33929;NS00004138;111GE013;DTXCID1028576;Feburic (TN);thyl-thiazole-5-carboxylic acid;AC-425;FEBUXOSTAT [MART.];BS-1018;AB01274796_02;CHEBI:31596;HMS3264C20;Febuxostat [USAN:INN:BAN];Goturic;Febric;DTXSID8048650;FEBUXOSTAT (MART.);Febuxostat, >=98% (HPLC);CHEMBL1164729;Febuxostat (JAN/USAN/INN);144060-53-7;Febuxostat- Bio-X;MFCD00871598;Febuxostat [USAN];Febuxostat,Uloric, TMX-67;FEBUXOSTAT [MI];FEBUXOSTAT [VANDF];Zurig;MLS006011568;NSC758874;SBI-0653454.0001;BRD-K48367671-001-05-9;BBL036503;BRD-K48367671-001-06-7;STL559020;FEBUXOSTAT? |